ClinicalTrials.gg
RecruitingNCT07237334Updated Nov 19, 2025

A Prospective Cohort Study of Clinical and Process Outcomes of Older Adults That Transition Through the Geriatric Emergency Medicine Unit(GEM-U)

An observational study in Frailty, sponsored by University of Limerick. Recruiting at 1 site in Ireland. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2025-11-19.

Sponsored by University of Limerick · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2026, 7 months ago, but the record still lists the study as recruiting.
  • Started Feb 2025; still recruiting 1 year 9 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
75 Years and older
Sex
All
01

Study summary

This study will characterise the patients using the Geriatric Emergency Medicine Unit, a unit which provides specialist care for patients aged 75 years and older attending the emergency department. It will examine how this specialist care impacts their health in terms of a number of different outcomes, such as; function, quality of life and health care usage; for example admission to the acute hospital.

Read the detailed description

The emergency department is a particularly challenging and busy environment, particularly for older adults living with frailty. It is widely acknowledged throughout the literature and national healthcare strategy that these older adults require holistic, person centred care that targets the intricacies of multifaceted, complex health issues.

The geriatric emergency medicine unit (GEM-U) aims to provide such care through the framework of comprehensive geriatric assessment, with in-put from a team of healthcare disciplines. The main aim of this study is to look at how this specialist care impacts patient outcomes, such as acute admission. Clinical and process outcomes of participants will be examined using patient reported outcome measures, which will include;

  1. Global measure of function (Barthel Index)
  2. Delirium screen (4AT +/- Delirium Rating Scale)*
  3. Frailty status (Clinical Frailty Scale)
  4. Nutritional status (Mini Nutritional Assesment)
  5. Quality of life (EuroQoL-5D-5L).
  6. Patient satisfaction (PSQ-18).

Participants will be followed at 30 days and 6 months post recruitment. All participants will give fully informed consent. The STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) standardised reporting guidelines will be followed in the conduct and reporting of this research. Data will be statistically analysed

02

Conditions studied

  • Frailty

Browse trials for

Keywords

  • Comprehensive Geriatric Assessment
03

In context

Frailty

1,284 studies on the registry are indexed under Frailty; 452 are open to participants now.

This study's planned enrollment of 150 is below the median of 225 across 493 observational studies indexed under Frailty.

Browse Frailty studies →

Lead sponsor

University of Limerick is the lead sponsor of 60 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
75 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All prospective older adults attending the GEMU that meet inclusion criteria will be invited to participate. However, this will be limited to the working hours of the research team (Monday-Friday, 8:00-20:00).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Older adults aged ≥75 years
  • Manchester Triage System category 2-5
  • Screen positive for risk of adverse outcomes after ED visit (≥ 2 on ISAR screening tool)
  • Presenting with a medical condition
  • Reviewed by the Older Persons Integrated Care Team

Exclusion criteria

Exclusion Criteria:

  • Patients presenting with a non-medical issue including major trauma or hip fracture

    • Patients presenting with acute stroke or
    • Patients more appropriate to another alternative pathway e.g. deep vein thrombosis pathway, low risk chest pain pathway
    • Patients with acute coronary syndrome or unstable arrthymia
    • Patients requiring care in the resuscitation room
    • Patients with head injury (unless appropriate assessment and management has been fully completed by ED team)
    • Patients with possible spinal injury (unless appropriate assessment and management has been fully completed by ED/orthopaedic team)
    • Patients with low Glasgow Coma Scale
    • Other exclusions at the discretion of the Older Persons Integrated Care team depending on team capacity and expertise
    • Exclusion criteria as set out above, are in line with those set out in the UHL Operating Policy of the Older Persons Integrated Care Team.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

TIA (transient ischaemic attack)

A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.

Stroke symptoms need emergency care at once, even if they go away.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Our primary outcome is incidence of hospital admission at index GEM-U presentation

    Patients who attend GEM-U and have an acute hospital admission at this time

    Time frame: Patients are followed at 30 days and 6 months

Secondary outcomes

  1. Mortality

    Mortality

    Time frame: Patients are followed at 30 days and 6 months

  2. Unscheduled ED revisit

    Patients who attend the ED department again during the follow up period

    Time frame: Patients are followed at 30 days and 6 months

  3. Unscheduled hospital visit(s)

    Patients who have unplanned hospital admission (i.e. not elective procedure) during follow up period

    Time frame: Patients are followed at 30 days and 6 months

  4. Nursing home admission

    Patients now living in a nursing home

    Time frame: Patients are followed at 30 days and 6 months

  5. Healthcare utilization (GP visit, out-patient geriatric services, PHN visit, HSCP services)

    Use of primary care and community care services

    Time frame: Patients are followed at 30 days and 6 months

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07237334
Lead sponsor
University of Limerick
Responsible party
Sponsor
First posted
Nov 19, 2025
Start date
Feb 10, 2025
Primary completion
Mar 30, 2026 (estimated)
Completion
Mar 30, 2026 (estimated)
Last update
Nov 19, 2025

Study contacts

Ida M Carroll, MSc
Contact
09006791@studentmail.ul.ie
0860638269 ext. 061482119
Rose Galvin
Contact
rose.galvin@UL.ie
0868463842
Ida Carroll
principal investigator · University of Limerick

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion